Anupam Rasayan keeps FY27 EBITDA margin at 22-24%.

Anupam Rasayan India Limited ANURAS maintains its FY27 EBITDA margin guidance at 22-24 percent. It also retains medium-term organic revenue growth guidance at 20-25 percent. H2 FY27 revenue is expected at ₹2,400-2,500 crore. This implies an annualised run rate of ₹4,800-5,000 crore. A specialty metal contract will add ₹100-150 crore in H2. The guidance supports steady growth and profitability for the specialty chemicals firm. Key numbers are 22-24 percent EBITDA margin, 20-25 percent revenue growth, H2 revenue of ₹2,400-2,500 crore and ₹100-150 crore from the specialty metal contract. These may support near-term interest in the stock. Peers such as Aarti Industries, SRF and Navin Fluorine could face relative comparison on guidance. Risks include slower demand or cost pressures. Competitors listed: Aarti Industries, SRF, Navin Fluorine. We have no financial interest in this news.